Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Tsanaclis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Arquivos De Neuro-Psiquiatria|September 1, 1981
[Determination of plasma levels of valproic acid (dipropylacetic acid) by gas chromatography]L M Tsanaclis, T G Garcia
Clinical Chemistry|May 1, 1993
Intra- and interlaboratory sources of imprecision in drug measurements by different techniquesL M Tsanaclis, J F Wilson
Therapeutic Drug Monitoring|August 1, 1997
Comparison by external quality assessment of performance of analytical systems for measurement of therapeutic drugs in serumL M Tsanaclis, J F Wilson
Therapeutic Drug Monitoring|December 1, 1996
External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serumJ F Wilson, L M Tsanaclis, K Barnett
Therapeutic Drug Monitoring|May 1, 1991
Determination of vigabatrin in plasma by reversed-phase high-performance liquid chromatographyL M Tsanaclis, J Wicks, J Williams, et al.
Journal of Mental Deficiency Research|December 1, 1985
Calcium homeostasis in mentally handicapped epileptic patientsS Deb, V A Cowie, L M Tsanaclis, et al.
British Journal of Clinical Pharmacology|May 1, 1986
Pharmacokinetics of antipyrine in epileptic patientsE M Rimmer, P A Routledge, L M Tsanaclis, et al.
Arquivos De Neuro-Psiquiatria|September 1, 1987
[Loading-doses of carbamazepine and diphenylhydantoin: use in high-risk patients]P J Leite, L M Tsanaclis, T Markourakis, et al.
British Journal of Clinical Pharmacology|July 1, 1984
Effect of valproate on free plasma phenytoin concentrationsL M Tsanaclis, J Allen, E Perucca, et al.
Therapeutic Drug Monitoring|April 1, 1995
Time course of appearance of cotinine in human beard hair after a single dose of nicotineS H Gwent, J F Wilson, L M Tsanaclis, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Arquivos De Neuro-Psiquiatria|September 1, 1981
[Determination of plasma levels of valproic acid (dipropylacetic acid) by gas chromatography]L M Tsanaclis, T G Garcia
Clinical Chemistry|May 1, 1993
Intra- and interlaboratory sources of imprecision in drug measurements by different techniquesL M Tsanaclis, J F Wilson
Therapeutic Drug Monitoring|August 1, 1997
Comparison by external quality assessment of performance of analytical systems for measurement of therapeutic drugs in serumL M Tsanaclis, J F Wilson
Therapeutic Drug Monitoring|December 1, 1996
External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serumJ F Wilson, L M Tsanaclis, K Barnett
Therapeutic Drug Monitoring|May 1, 1991
Determination of vigabatrin in plasma by reversed-phase high-performance liquid chromatographyL M Tsanaclis, J Wicks, J Williams, et al.
Journal of Mental Deficiency Research|December 1, 1985
Calcium homeostasis in mentally handicapped epileptic patientsS Deb, V A Cowie, L M Tsanaclis, et al.
British Journal of Clinical Pharmacology|May 1, 1986
Pharmacokinetics of antipyrine in epileptic patientsE M Rimmer, P A Routledge, L M Tsanaclis, et al.
Arquivos De Neuro-Psiquiatria|September 1, 1987
[Loading-doses of carbamazepine and diphenylhydantoin: use in high-risk patients]P J Leite, L M Tsanaclis, T Markourakis, et al.
British Journal of Clinical Pharmacology|July 1, 1984
Effect of valproate on free plasma phenytoin concentrationsL M Tsanaclis, J Allen, E Perucca, et al.
Therapeutic Drug Monitoring|April 1, 1995
Time course of appearance of cotinine in human beard hair after a single dose of nicotineS H Gwent, J F Wilson, L M Tsanaclis, et al.
Pageof 2